Round‑table panel at IDMA’s “Pharma IP Update 2025” webinar, featuring Dr Gopakumar G. Nair, Krrishan Singhania, Srishti Singhania and fellow experts, alongside key slides on trademark importance and anti‑counterfeit strategies.

Round‑table panel at IDMA’s “Pharma IP Update 2025”

The Indian Drug Manufacturers’ Association (IDMA) kicked off its first IP‑centric webinar with a packed house of pharmaceutical leaders, regulators, and IP professionals. After a warm welcome by Shri Dara B. Patel (Secretary‑General, IDMA) and opening remarks from Shri Bharat Shah (National President, IDMA), the session moved straight into high‑value insights:

  • KeynoteDr Gopakumar G. Nair traced India’s patent journey, shared real‑world obstacles in drug protection, and mapped the way forward for stronger, innovation‑friendly policy.

  • Trademark Deep‑DiveKrrishan Singhania and Srishti Singhania highlighted why pharma trademarks are more than brand badges:

    • Preventing look‑alike / sound‑alike (LASA) medication errors

    • Securing market exclusivity long after patents expire

    • Combatting counterfeits with Customs recordal, QR codes & holograms

    • Case in point: Johnson & Johnson v Preetam Das Arora – ₹3.34 crore damages awarded for spurious drugs

  • Panel Discussion – Experts unpacked biosimilar patents, e‑pharma monitoring, and sequencing patents, then fielded an energetic Q&A.


Five Takeaways for Pharma Teams

  1. Trademark vigilance saves lives – LASA risks demand rigorous name‑clearance and packaging audits.

  2. Early market entry ≠ automatic rights – continuous watch services are essential.

  3. Counterfeit defence toolbox – Customs recordal, civil suits, tech markers, and awareness drives.

  4. Biosimilars need dual shields – patent layering plus distinctive branding.

  5. Digital pharmacies amplify risk – monitor online marketplaces as closely as offline shelves.

8 July 2025 | Hybrid (Mumbai + Zoom)

Subscribe to our Newsletter

Sign up for daily, weekly, monthly newsletter to get the latest news updates delivered directly to your inbox.

Insights

Update Yourself With The Indian Laws & The Recent Developments

Testimonial

What Our Clients Say